Cargando…
Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis
BACKGROUND: 23 million Americans suffer from migraine headaches, incurring more than $1 billion in direct medical costs each year (with another $13 billion in indirect productivity losses). Triptans are the most common treatment of choice for these patients; however, adherence and persistence to tri...
Autores principales: | Messali, Andrew, Owens, Gary, Bloudek, Lisa, Kori, Shashidhar, Cole, Ashley, Chia, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437956/ https://www.ncbi.nlm.nih.gov/pubmed/24684641 http://dx.doi.org/10.18553/jmcp.2014.20.4.368 |
Ejemplares similares
-
Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
por: Zebenholzer, Karin, et al.
Publicado: (2018) -
Comparison of healthcare resource utilization and costs among
patients with migraine with potentially adequate and insufficient triptan
response
por: Marcus, Steven C, et al.
Publicado: (2020) -
All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001) -
Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001) -
Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)